康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00867 康哲药业

开市前 02-27 09:21:11

14.630

+0.000

0.00%

最高14.630	最低14.630	成交量0.00
今开14.630	昨收14.630	日振幅0.00%
总市值356.97亿	流通市值356.90亿	总股本24.40亿
成交额0.00	换手率0.00%	流通股本24.40亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":14.63,"timestamp":1772154000069,"preClose":14.63,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":2439528512,"shares":2440000000,"eps":0.667298,"marketStatus":"开市前","change":0,"latestTime":"02-27 09:21:11","open":14.63,"high":14.63,"low":14.63,"amount":0,"amplitude":0,"askPrice":14.57,"askSize":10000,"bidPrice":14.11,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.748149,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772155800000},"marketStatusCode":1,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":14.63,"dividendRate":0.021213,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"2614055548","title":"每日卖空追踪 | 康哲药业 02月25日卖空量成交27万股，卖空比例为6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614055548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614055548?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008218,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月25日，涨1.53%，卖空量成交27万股，较上一交易日减少33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163149a4c6729c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163149a4c6729c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","IE00BMCWC346.EUR","BK1191","SG9999015986.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","00867","SG9999015978.USD","SG9999015952.SGD","SG9999004220.SGD","BK1593"],"gpt_icon":0},{"id":"2614778777","title":"信达证券：首予康哲药业(00867)“买入”评级 创新转型迎业绩长周期增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2614778777","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614778777?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:52","pubTimestamp":1771984329,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，信达证券发布研报称，首次覆盖，给予康哲药业“买入”评级，该行预计2025-2027年公司营业收入分别为82.16亿元、98.59亿元、120.28亿元，同比增速分别为10%、20%、22%;归母净利润分别为16.15亿元、18.50亿元、22.38亿元，同比增速分别为0%、15%、21%。该行看好公司中长期成长性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00867","601059"],"gpt_icon":0},{"id":"1182063591","title":"康哲药业(867.HK/8a8.SG)：磷酸鲁索替尼乳膏新增特应性皮炎适应症上市申请获中国药监局受理并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1182063591","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182063591?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:37","pubTimestamp":1771940220,"startTime":"0","endTime":"0","summary":"康哲药业宣布，其磷酸鲁索替尼乳膏用于新增适应症——特应性皮炎（AD）的新药上市申请（NDA），已获得中国国家药品监督管理局的正式受理，并被纳入优先审评程序。这一进展有望加速该产品在中国市场的上市进程，为特应性皮炎患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE00BVYPNQ40.USD","BK1593","LU2488822045.USD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","BK1191","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","00867","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"1174404047","title":"康哲药业芦可替尼乳膏新增适应症上市申请获受理并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1174404047","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174404047?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:54","pubTimestamp":1771926861,"startTime":"0","endTime":"0","summary":"康哲药业宣布，其芦可替尼乳膏新增适应症（特应性皮炎）的上市申请已获中国国家药品监督管理局正式受理，并被纳入优先审评程序。此举有望加速该产品在中国市场的准入进程，为特应性皮炎患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","IE00BYV24P56.USD","SG9999004220.SGD","BK1191","LU2488822045.USD","SG9999015978.USD","00867","IE00BGHQDM52.EUR","SG9999015986.USD","BK1593"],"gpt_icon":0},{"id":"1125052120","title":"康哲药业芦可替尼磷酸酯乳膏治疗特应性皮炎新药申请获中国国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1125052120","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125052120?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:49","pubTimestamp":1771926587,"startTime":"0","endTime":"0","summary":"康哲药业宣布，其用于治疗特应性皮炎的芦可替尼磷酸酯乳膏新药申请，已正式获得中国国家药品监督管理局的受理。这一进展标志着该药物在中国上市审批流程中迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","BK1191","00867","IE00BVYPNP33.GBP","BK1593","SG9999015978.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2613871794","title":"康哲药业(00867)：创新药磷酸芦可替尼乳膏增加特应性皮炎(AD)适应症中国上市许可申请获受理并获纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2613871794","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613871794?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:49","pubTimestamp":1771926559,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，旗下德镁医药有限公司已于2026年2月24日获得中国国家药品监督管理局受理磷酸芦可替尼乳膏轻中度特应性皮炎的新药上市许可申请。且该项NDA因“符合儿童生理特征的儿童用药品新品种、剂型和规格”，已获得NMPA药品审评中心批准纳入优先审评品种名单，有望加快产品AD适应症上市审评进程。此次增加AD适应症NDA获受理，是产品向多治疗领域拓展的关键里程碑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNP33.GBP","BK1161","00867","159992","BK1574","SG9999015986.USD","SG9999015945.SGD","06978","LU2488822045.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999015978.USD","BK4132","AD","BK1593","BK1191","SG9999004220.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2613748055","title":"康哲药业(0867.HK)：商业化能力卓越 创新转型迎业绩长周期增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2613748055","media":"信达证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613748055?lang=zh_cn&edition=full","pubTime":"2026-02-24 00:00","pubTimestamp":1771862400,"startTime":"0","endTime":"0","summary":"国内商业化能力卓越，海外东南亚市场研产销布局完备公司具备卓越的、覆盖全链路的商业化能力，拥有约4700 人的专业学术推广团队，网络深度覆盖中国超5 万家医院及医疗机构、约30 万家零售药店及主流电商平台，能够高效驱动产品放量。国际化战略方面，公司前瞻性地在东南亚市场构建了完整的研发+注册与商业化+生产一体化布局，为公司打开了长期、可持续的第二增长曲线。我们看好公司中长期成长性，首次覆盖给予“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224202659a4c309cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224202659a4c309cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015945.SGD","SG9999004220.SGD","BK1593","IE00BMCWC346.EUR","00867","SG9999015952.SGD","SG9999015978.USD","BK1191","IE00BVYPNP33.GBP","SG9999015986.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2613736053","title":"每日卖空追踪 | 康哲药业 02月23日卖空量成交2.7万股，卖空比例为1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613736053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613736053?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835416,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月23日，涨1.98%，卖空量成交2.7万股，较上一交易日减少87.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163140a71562db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163140a71562db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","SG9999004220.SGD","00867","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","IE00BYV24P56.USD","LU2488822045.USD","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015945.SGD","BK1191"],"gpt_icon":0},{"id":"2613215541","title":"每日卖空追踪 | 康哲药业 02月20日卖空量成交8.3万股，卖空比例为6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613215541","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613215541?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576216,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月20日，跌1.24%，卖空量成交8.3万股，较上一交易日减少33.06%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163153a70cce2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163153a70cce2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015978.USD","00867","LU2488822045.USD","SG9999004220.SGD","BK1191","BK1593","SG9999015945.SGD","SG9999015952.SGD","SG9999015986.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2610941640","title":"康哲药业(00867)：签订原研药Lidoderm®利多卡因凝胶贴膏独家经销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2610941640","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610941640?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:00","pubTimestamp":1770890434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，于2026年2月12日，本集团通过本公司附属公司与TeikokuPharma USA, Inc.就Lidoderm利多卡因凝胶贴膏(产品)签订独家经销协议(协议)。1999 年美国食品药品监督管理局批准5% 利多卡因贴剂上市，用于带状疱疹后神经痛的治疗。该产品2007年以商品名Versatis被欧盟批准上市，并于2024年在中国获批上市。利多卡因外用贴膏/贴剂用于PHN的治疗已得到国内外临床实践指南共识的支持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00867","IE00BMCWC346.EUR","SG9999015952.SGD","SG9999015978.USD","IE00BYV24P56.USD","BK1593","IE00BVYPNP33.GBP","SG9999004220.SGD","SG9999015986.USD","BK1191","IE00BVYPNQ40.USD","SG9999015945.SGD","LU2488822045.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"1100240543","title":"康哲药业签署利多卡因贴片利多卡因贴剂独家分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1100240543","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100240543?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:55","pubTimestamp":1770890113,"startTime":"0","endTime":"0","summary":"康哲药业宣布，公司已正式签署关于Lidoderm利多卡因贴片的独家分销协议。该协议的签署标志着公司在疼痛管理领域产品线的进一步拓展，将有助于提升其在中国医药市场的竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","IE00BMCWC346.EUR","LU2488822045.USD","SG9999015978.USD","IE00BVYPNP33.GBP","SG9999004220.SGD","SG9999015952.SGD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","SG9999015986.USD","BK1191","00867","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2610919168","title":"国联民生证券：小核酸重构减肥逻辑 INHBE与ALK7靶点初步验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2610919168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610919168?lang=zh_cn&edition=full","pubTime":"2026-02-12 14:27","pubTimestamp":1770877647,"startTime":"0","endTime":"0","summary":"小核酸减肥靶点主要有INHBE靶点、ARO-ALK7靶点以及靶向肌肉的GeneD靶点三个，中国药企在小核酸减肥适应症的布局速度几乎与海外药企同步。国联民生证券主要观点如下：Arrowhead公布两款小核酸药物的初步减肥疗效良好Arrowhead公司公布了两个靶点INHBE和ALK7的小核酸药物的减肥效果，展现出良好的初步疗效：ARO-INHBE精准减脂：脂肪平均减少9.9%，肝脏脂肪减少幅度高达38.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNQ40.USD","BK1521","01276","IE00BGHQDM52.EUR","SG9999015978.USD","IE00BZ08YS42.EUR","IE00BYV24P56.USD","00867","IE00BVYPNP33.GBP","LU0359201612.USD","LU0359202008.SGD","IE00BZ08YR35.GBP","BK1564","BK0276","601456","LU2488822045.USD","SG9999015945.SGD","IE00BMCWC346.EUR","LU0359201885.HKD","LU2543165471.USD","SG9999015952.SGD","BK1515","BK1589","SG9999004220.SGD","01177","LU1023057109.AUD","BK1593","161027","HK0000165453.HKD","IE00BZ08YT58.USD","SG9999015986.USD","BK1147","01456","BK1191"],"gpt_icon":0},{"id":"2610487645","title":"加速全球化布局：英硅智能联手康哲药业、信达生物88.5亿美元出海、复方丹参滴丸美国梦碎","url":"https://stock-news.laohu8.com/highlight/detail?id=2610487645","media":"中国粉体网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610487645?lang=zh_cn&edition=full","pubTime":"2026-02-10 17:29","pubTimestamp":1770715757,"startTime":"0","endTime":"0","summary":"中国粉体网讯1、英硅智能：与康哲药业达成药物研发战略合作2月10日英硅智能发布公告，其已与康哲药业达成药物研发战略合作。这是中国首款、全球第二款进入临床的VAV1分子胶降解剂。根据协议条款，公司将获得3.5亿美元首付款；在达成后续特定里程碑事件后，还有资格获得总额最高约85亿美元的研发、监管及商业化里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210172925a492f653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210172925a492f653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","IE00BVYPNP33.GBP","01801","LU0455707207.USD","BK1161","BK1589","LU2097828474.EUR","HK0000165453.HKD","03696","LU2488822045.USD","SG9999004220.SGD","BK1593","IE00BYV24P56.USD","SG9999015978.USD","SG9999015945.SGD","IE00BVYPNQ40.USD","LU2328871848.SGD","SG9999015986.USD","LU0502904849.HKD","LU1969619763.USD","LU2097828557.USD","LU2097828631.EUR","BK1141","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","LU2097828714.EUR","LU2097828805.USD","LU2242644610.SGD","BK1191","SG9999015952.SGD","BK1583"],"gpt_icon":1},{"id":"2610732626","title":"每日卖空追踪 | 康哲药业 02月10日卖空量成交76.7万股，卖空比例为14.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610732626","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610732626?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712217,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月10日，跌0.4%，卖空量成交76.7万股，较上一交易日减少25.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163157a492b7bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163157a492b7bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","BK1191","00867","IE00BVYPNP33.GBP","BK1593","SG9999015978.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹，广生堂涨超10%，此前万邦德涨停，尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出，经历短期波动消化后，创新药板块已显现企稳回暖迹象。整体上，国金证券认为创新药前期回调较为充分，向上产业趋势明确，催化近期密集，继续看好板块投资机会。从未来增长潜力来看，多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00867","02269","BK1515","01513","01276","BK1574","06160","01952","06978","00512","03692","00013","01093","02096","02196","01177","BK1583","01801","01877","01548","02228","06185"],"gpt_icon":0},{"id":"2610768667","title":"英硅智能(03696)与康哲药业达成数千万港元的中枢神经系统及自身免疫疾病领域的多个药物研发项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2610768667","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610768667?lang=zh_cn&edition=full","pubTime":"2026-02-10 08:15","pubTimestamp":1770682532,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能(03696)发布公告，集团已与康哲药业达成药物研发战略合作。透过该合作，双方将在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据该合作的协议条款，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，共同推进不少于2个研发项目的合作开发。同时，英硅智能有望就每个项目获得最高达数千万港元的研发费用支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7323b9e43cf2c98249ddbdcb6770aa68","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","SG9999015945.SGD","BK1191","03696","LU2488822045.USD","BK1593","SG9999015978.USD","00867","IE00BGHQDM52.EUR","BK1141","SG9999015986.USD","IE00BMCWC346.EUR","SG9999004220.SGD","IE00BYV24P56.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2609451603","title":"每日卖空追踪 | 康哲药业 02月06日卖空量成交43.7万股，卖空比例为7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609451603","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609451603?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366617,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月06日，涨2.7%，卖空量成交43.7万股，较上一交易日减少60.84%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163202a6dabfa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163202a6dabfa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","SG9999004220.SGD","00867","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","IE00BYV24P56.USD","LU2488822045.USD","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015945.SGD","BK1191"],"gpt_icon":0},{"id":"2609516032","title":"康哲药业02月06日主力净流入444.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2609516032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609516032?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:15","pubTimestamp":1770365757,"startTime":"0","endTime":"0","summary":"02月06日, 康哲药业股价涨2.70%，报收15.24元，成交金额8689.0万元，换手率0.24%，振幅3.50%，量比0.90。康哲药业今日主力资金净流入444.7万元，上一交易日主力净流出3.3万元。该股近5个交易日上涨8.62%，主力资金累计净流入2217.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2571.0万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162137a6dab27a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162137a6dab27a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015945.SGD","BK1593","IE00BYV24P56.USD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","00867","BK1191","SG9999004220.SGD","IE00BVYPNQ40.USD","IE00BMCWC346.EUR","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"2608135488","title":"每日卖空追踪 | 康哲药业 02月04日卖空量成交39.5万股，卖空比例为14.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608135488","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608135488?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193816,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月04日，涨0.69%，卖空量成交39.5万股，较上一交易日减少78.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163317a47b0b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163317a47b0b76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","LU2488822045.USD","SG9999015978.USD","BK1191","BK1593","IE00BVYPNQ40.USD","00867","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","SG9999015952.SGD","SG9999015945.SGD","SG9999015986.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2608351002","title":"康哲药业02月04日获主力加仓11.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608351002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608351002?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:16","pubTimestamp":1770192961,"startTime":"0","endTime":"0","summary":"02月04日, 康哲药业股价涨0.69%，报收14.58元，成交金额4448.9万元，换手率0.13%，振幅3.45%，量比0.50。康哲药业今日主力资金净流入11.2万元，连续3日净流入，上一交易日主力净流入151.1万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为52.17%，平均涨幅为2.52%。该股近5个交易日上涨4.73%，主力资金累计净流入1508.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2356.0万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162327a6d1f668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162327a6d1f668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","SG9999015945.SGD","BK1593","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015978.USD","SG9999015986.USD","BK1191","00867","SG9999015952.SGD","SG9999004220.SGD","IE00BGHQDM52.EUR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":-0.0457},{"period":"1month","weight":0.0601},{"period":"3month","weight":0.1},{"period":"6month","weight":0.1185},{"period":"1year","weight":0.8002},{"period":"ytd","weight":0.1341}],"compareEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.0275},{"period":"3month","weight":0.0202},{"period":"6month","weight":0.052},{"period":"1year","weight":0.109},{"period":"ytd","weight":0.0293}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事药品生产、营销、推广及销售业务的投资控股公司。该公司的产品包括波依定、优思弗、施图伦滴眼液、喜辽妥、艾蓓尔产品系列及Vmonalisa莫娜丽莎等。其主要在售产品覆盖心脑血管、消化、眼科、皮肤科及医美领域。该公司主要在中国国内和海外市场销售其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.010984},{"month":2,"riseRate":0.6,"avgChangeRate":0.034806},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.002353},{"month":4,"riseRate":0.533333,"avgChangeRate":0.029521},{"month":5,"riseRate":0.466667,"avgChangeRate":0.01146},{"month":6,"riseRate":0.666667,"avgChangeRate":0.005887},{"month":7,"riseRate":0.533333,"avgChangeRate":-0.008683},{"month":8,"riseRate":0.4,"avgChangeRate":0.021846},{"month":9,"riseRate":0.466667,"avgChangeRate":0.00566},{"month":10,"riseRate":0.5,"avgChangeRate":0.008421},{"month":11,"riseRate":0.5625,"avgChangeRate":0.054281},{"month":12,"riseRate":0.5625,"avgChangeRate":0.03433}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}